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COVID-19 MORTALITY RISK FACTORS IN HOSPITALIZED
PATIENTS: A LOGISTIC REGRESSION MODEL
FACTORES DE RIESGO DE MORTALIDAD POR COVID-19 EN PACIENTES HOSPITALIZADOS: UN MODELO
DE REGRESIÓN LOGÍSTICA
Irma Yupari-Azabache1,a, Lucia Bardales-Aguirre2,b, Julio Rodriguez-Azabache3,c,
J. Shamir Barros-Sevillano3,4,d, Ángela Rodríguez-Diaz5,3,e

ABSTRACT

ORIGINAL PAPER

Introduction: The population is susceptible to COVID-19 and knowing the most predominant characteristics
and comorbidities of those affected is essential to diminish its effects. Objective: This study analyzed the
biological, social and clinical risk factors for mortality in hospitalized patients with COVID-19 in the district of
Trujillo, Peru. Methods: A descriptive type of study was made, with a quantitative approach and a correlational,
retrospective, cross-sectional design. Data was obtained from the Ministry of Health’s database, with a sample
of 64 patients from March to May 2020. Results: 85,71% of the total deceased are male, the most predominant
occupation is Retired with an 28,57% incidence, and an average age of 64,67 years. When it came to symptoms
of deceased patients, respiratory distress represents the highest percentage of incidence with 90,48%,
then fever with 80,95%, followed by malaise in general with 57,14% and cough with 52,38%. The signs that
indicated the highest percentage in deaths were dyspnea and abnormal pulmonary auscultation with 47,62%,
in Comorbidities patients with cardiovascular disease were found in 42,86% and 14,29% with diabetes. The
logistic regression model to predict mortality in hospitalized patients allowed the selection of risk factors such
as age, sex, cough, shortness of breath and diabetes. Conclusion: The model is adequate to establish these
factors, since they show that a fairly considerable percentage of explained variation would correctly classify
90,6% of the cases.
Key words: Risk; Mortality; COVID-19; Comorbidity; Hospitalization (source: MeSH NLM).

RESUMEN

Introducción: La población es susceptible al COVID-19 y conocer las características y comorbilidades más
predominantes de los afectados resulta imprescindible para disminuir sus efectos. Objetivo: El presente
estudio analizó los factores biológicos, sociales y clínicos de riesgo de mortalidad en pacientes hospitalizados
con COVID-19 en el distrito de Trujillo, Perú. Métodos: El tipo de estudio fue descriptivo, de enfoque
cuantitativo y diseño correlacional, retrospectivo, de corte transversal. Se obtuvieron los datos del sistema
del Ministerio de Salud, con una muestra de 64 pacientes de marzo a mayo del 2020. Resultados: El 85,71%
del total de fallecidos son del sexo masculino, la ocupación más predominante es jubilados con un 28,57%
y tienen una edad promedio de 64,67 años. En el caso de los síntomas en pacientes fallecidos la dificultad
respiratoria representa el mayor porcentaje 90,48%; la fiebre con un 80,95%, seguido de un malestar en
general con un 57,14% y tos con un 52,38%. Los signos con mayor porcentaje en fallecidos fueron la disnea y
auscultación pulmonar anormal con un 47,62%, en Comorbilidades se encontraron pacientes con enfermedad
cardiovascular en un 42,86% y un 14,29% con diabetes. El modelo de regresión logística para predecir la
mortalidad en pacientes hospitalizados permitió la selección de factores de riesgo como edad, sexo, tos,
dificultad respiratoria y diabetes. Conclusión: El modelo es el adecuado para establecer estos factores, ya
que muestran que un porcentaje de variación explicada bastante considerable, clasificaría correctamente el
90,6% de los casos.
Palabras clave: Riesgo; Mortalidad; COVID-19; Comorbilidad; Hospitalizados (fuente: DeCS BIREME).
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INTRODUCTION
On December 31, 2019, the Chinese government
first reported an outbreak of the coronavirus disease
(COVID-19) in Wuhan, the capital of Hubei province
in China. This pandemic has spread rapidly from this
city to all the areas of China and worldwide(1).

ORIGINAL PAPER

In Latin America, the first case was registered in Brazil
on February 26, and the first death was reported in
Argentina on March 7. Although the first confirmed
cases were people arriving from trips, community
contagion spread the pandemic to different
countries on this continent, reaching Peru on March
6 of this year(2).
On March 15, the Peruvian government declared the
country in a state of emergency, but despite this, the
infections have been increasing, so that hospitals
have collapsed. As of September 7, Peru reports
676,848 confirmed cases and 29,554 deceased
cases, being the fifth country with the most infected
worldwide and the first in deaths per million people,
becoming the main public health and economic
problem in the country(3,4).
Trujillo is one of the most populated districts in the
department of La Libertad, located in the north of the
country. To date, it counts more than 8,000 infected
and more than 800 deaths; hospitals have collapsed
to such an extent that people stand in long lines to
be treated and some die without being treated(5).
The population is generally susceptible to this virus;
however, within the characteristics of those affected,
males and people with comorbidities have been
more noticeable. Therefore, mortality generally
occurs in older adults and people with diabetes,
hypertension, obesity, and cardiovascular diseases(6,7).
Thus, a study carried out in Cuba shows that in most
cases it has a clinical picture corresponding to a selflimited upper respiratory infection, with a variety of
symptoms according to risk groups, presenting a
rapid progression to severe pneumonia and multiorgan failure, generally fatal in the elderly and with
the presence of comorbidities(8).
Most people show symptoms in an interval of 3 to
7 days after infection, but in some, it can take up
to 14 days, and infect others without realizing it.
Symptoms can include fever, runny nose, sore throat,
cough, fatigue, muscle aches, shortness of breath,
sputum, hemoptysis, and diarrhea(9).
Another study conducted in China shows that
patients diagnosed with COVID-19 were middle-
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aged (56 years), the majority (62%) were men, and
around half (48%) had underlying chronic conditions
being the most common arterial hypertension (30%)
and diabetes (19%). Also, from the onset of the
disease, the median time to discharge was 22 days,
and the average time to death was 18.5 days(10). The
average number of new cases per infected ranges
between 2.24 (95% CI: 1.96-2.55) and 3.58 (95% CI:
2.89-4.39). A person can infect approximately 2 to 4
people(11).
A study carried out in Spain confirms that older
adults living in residences are an important factor
associated with mortality; regression models
indicate a significant effect of temperature on the
differences in incidence between the autonomous
communities(12).
In Peru, patients with COVID-19 who were admitted
to a public hospital in Lima, had a high mortality
rate. It was independently associated with oxygen
saturation, admission, and age over 60 years(13).
Due to the above, and wanting to contribute to
research that helps us expand our knowledge
of this disease, we ask ourselves the following
question: What are the risk factors for mortality in
hospitalized patients with COVID-19 in the Trujillo
district? It was considered a research hypothesis
that biological factors, such as gender and age;
social like occupation; Clinical factors such as signs,
symptoms, and comorbidities are risk factors for
mortality in patients hospitalized for COVID-19
in the district Trujillo. As a general objective, we
establish the analysis of biological, social, and clinical
risk factors for mortality in hospitalized patients
with COVID-19 in the Trujillo district. The study has
specific objectives to propose a logistic regression
model that allows determining the risk factors for
mortality in hospitalized patients by COVID-19 in the
Trujillo district, and estimate the degree of fit of the
model to predict the death of hospitalized patients
from COVID-19.

METHODS
Design and study area
Descriptive type of study, with a quantitative
approach and correlational, retrospective, crosssectional design(14).

Population and sample
The population consisted of all hospitalized patients
in the Trujillo district with COVID 19 treated in the
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Trujillo microgrid. The information was obtained
from the health ministry system, selecting a sample
of 64 patients who met the selection criteria and
who were collected during the period from March to
May 2020.

Procedure and variables
For data collection, the applied technique was the
documentary analysis and the instrument the data
collection sheet approved by the Ministry of Health
and regulated within the System of the National
Center for Epidemiology, prevention and control of
diseases. Biological variables, such as gender and age,
were reviewed; social like occupation; and clinical
factors such as signs, symptoms and comorbidities.
For the analysis of the information, an Excel database
was elaborated, the analysis was carried out in the SPSS
version 26 Program. To identify the biological, social
and clinical factors of risk of mortality in hospitalized
patients with COVID-19, binary logistic regression
analysis was performed using Ward's method; and to
estimate the degree of fit of the model, the ROC curve
was applied(15).

RESULTS
64 patients with COVID-19 hospitalized between
March 1 and May 31, 2020, were identified. The
mean age of the patients was 52.56 years (+/- 20.27),
being male (68.8 %) with higher cases. The other
epidemiological characteristics are presented in
Table 1.
The most frequent clinical manifestations found
in hospitalized patients were fever, respiratory
distress, general malaise, cough, and abnormal lung
auscultation (Table 2). Likewise, among the preexisting comorbidities, cardiovascular disease was
the most frequent comorbidity (Table 3).
In Table 4, it shows us that by means of the method in
front of Wald it allowed the selection of the variables
Age, gender, Cough, Respiratory difficulty, Joint pain
and Diabetes, so the model would be as follows:

The OR value of the gender variable is equal to 0.008
(CI: 0.000-0.258), where both values are less than 1.
Therefore, the female gender reduces the probability
of mortality (death) of patients hospitalized for
COVID-19.
The OR value of the cough variable is 0.055 (CI: 0.0050.648), where both values are less than 1. Therefore,
the fact that a person has symptoms of cough reduces
the probability of mortality (death) of the patients
hospitalized for COVID-19.
The OR value of the respiratory distress variable is
89.703 (CI: 3.575-2250.718), where both values are
greater than 1. Therefore, the fact that a person
presents respiratory distress symptoms increases
the probability of mortality or death of patients
hospitalized for COVID-19.
The OR value of the joint pain variable is 37.099 (CI:
0.619-222.044); the interval includes 1. Therefore, the
fact that a person presents a joint pain symptom is
not significant to determine the mortality of patients
hospitalized for COVID-19, so this variable is not
included in the model.
The OR value of the diabetes variable is 77.478 (CI:
1.167-5142.378), where both values are greater than
1. Therefore, the fact that a person has comorbidity
of diabetes increases the probability of mortality or
death of patients hospitalized for COVID-19.
The model summary shows a minimal value of -2LL
(-2 Logarithm of the likelihood), which indicates that
the model obtained, in step 6, is better suited to the
data than the models in the previous steps. Likewise,
the coefficients of determination of R squared of Cox
and Snell and R squared of Nagelkerke, indicate that
50.2% and 69.9% of the variation of the dependent
variable death, is explained by the variables included
in the model, showing a considerable percentage of
explained variation(15-17).

X1: Age, X2: gender, X3: Cough, X4: Respiratory
difficulty, X5: Diabetes

The Hosmer-Lemeshow test for step 6 allows us to
study the goodness of fit of the logistic regression
model, having as a null hypothesis that there are no
differences between the observed and predicted
values, where the p-value of significance is greater
than 0, 05 (p = 0.396> 0.05), therefore, we conclude
that the model is well adjusted to the data(15).

The OR value of the Age variable is equal to 1.11 (CI:

Table 5 shows us that of the 43 patients hospitalized

Where Y: Mortality (Deceased / Not Deceased)

Published by INICIB-URP, 2021
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Statistical analysis

1.029-1.206), where both values are greater than
1. Therefore, the fact that a person is older is a risk
factor mortality (death) of patients hospitalized for
COVID -19.
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for COVID-19 in the Trujillo district who did not die,
40 patients are classified by the model, representing
93%, and of the 21 patients hospitalized for
COVID-19 that did die, there are a total of 18 patients
well classified by the model, representing 85.7%. It
is expected that in the population the model would
correctly classify 90.6% of the cases(16,17).

Figure 1 shows that the AUC (area under the ROC
curve) for the model is equal to 0.95 (95% CI: 0.890 to
1). The result leads to rejecting the null hypothesis of
non-discrimination (p <0.000). It is concluded that the
model provides excellent discrimination power (15).

Table 1. General characteristics of patients hospitalized for COVID-19 who died or not in the district of
Trujillo, Peru
Characteristic

Deceased
Yes (n = 21)

ORIGINAL PAPER

n
Age

%

64.67 ± 16.88

No (n = 43)
n

%

46.65 ± 16.88

Total (n = 64)
n

%

52.56 ± 20.27

Gender
Male

18

85.7

26

60.5

44

68.8

Female

3

14.3

17

39.5

20

31.3

Student

0

0

2

4.7

2

3.1

Works with animals

0

0

1

2.3

1

1.6

Health worker

1

4.7

1

2.3

2

3.1

Others

20

95.2

39

90.7

59

92.2

Housewife

3

14.3

10

23.3

13

20.3

Unknown

5

23.8

5

11.6

10

15.6

Military

1

4.7

7

16.3

8

12.5

Retired

6

28.6

1

2.3

7

10.9

Employee

1

4.8

4

9.3

5

7.8

Entrepreneur / merchant

1

4.8

4

9.3

5

7.8

Independent

0

0

5

11.6

5

7.8

Driver

2

9.5

1

2.3

3

4.7

Mine worker

1

4.8

1

2.3

2

2.3

worker Agribusiness

0

0

1

2.3

1

1.6

Occupation

Source: Data obtained from the COVID19 registry system of the Ministry of Health, March as of May 2020.
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Table 2. Signs and symptoms of patients hospitalized for COVID-19 who died or not in the district of Trujillo,
Peru.

Death

Signs

Temperature
Dyspnoea

Auscultation abnormal lung

Abnormal findings lung Rx

Yes (n = 21)

No (n = 43)

n

n

%

37.6 ± 0.9

%

37.4 ± 0.9

Total (n = 64)
n

%

37.4 ± 0.9

10

47.6

17

39.5

27

42.2

No

11

52.4

26

60.4

37

57.8

Yes

10

47.6

24

55.8

34

53.1

No

11

52.4

19

44.2

30

46.8

Yes

7

33.3

19

44.2

26

40.6

No

14

66.7

24

55.8

38

59.4

Yes

17

81.0

34

79.1

51

79.7

No

4

19.1

9

20.9

13

20.3

Yes

12

57.1

28

65.1

40

62.5

No

9

42.9

15

34.88

24

37.5

Yes

11

52.4

28

65.1

39

61.0

No

10

47.6

15

34.8

25

39.1

Yes

4

19.1

19

44.2

23

35.9

No

17

81.0

24

55.8

41

64.1

Yes

19

90.5

20

46.5

39

60.9

No

2

9.5

23

53.5

25

39.1

Yes

3

14.3

9

20.9

12

18.8

No

18

85.7

34

79.1

52

81.3

Yes

2

9.5

6

14.0

8

12.5

No

19

90.5

37

86.1

56

87.5

Yes

2

9.5

13

30.2

15

23.4

No

19

90.5

30

69.8

49

76.6

Yes

5

23.8

13

30.2

18

28.1

No

16

76.2

30

69.8

46

71.9

Yes

1

4.8

2

4.7

3

4.7

No

20

95.24

41

95.4

61

95.3

Yes

2

9.5

12

27.9

14

21.9

No

19

90.5

31

72.1

50

78.1

Yes

1

4.8

2

4.7

3

4.7

No

20

95.2

41

95.4

61

95.3

Symptoms
Fever
General malaise

Cough

Sore throat

Shortness of breath

Diarrhea

Nausea
Headache
Muscle pain
Abdominal pain

Chest pain

Joint pain

ORIGINAL PAPER

Yes

Source: Data obtained from the COVID19 registry system of the Ministry of Health, March to May 2020.
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Table 3. Comorbidities of patients hospitalized for COVID 19 who died or not in the Trujillo district, Peru.
Died

Comorbidities

Yes (n = 21)

Cardiovascular disease
(includes hypertension)

ORIGINAL PAPER

Diabetes

Chronic lung disease

Cancer

No (n = 43)

Total (n = 64)

n

%

n

%

n

%

Yes

9

42.9

9

20.9

18

28.1

No

12

57.1

34

79.1

46

71.9

Yes

3

14.3

1

2.3

4

6.3

No

18

85.7

42

97.7

60

93.8

Yes

2

9.5

0

0

2

3.3

No

19

90.5

43

100

62

96.9

Yes

3

14.3

0

0

3

4.7

No

18

85.7

43

100

61

95.3

Source: Data obtained from COVID19 registry system of the Ministry of Health, March to May 2020.

Table 4. Selection of variables associated with the mortality of patients hospitalized by COVID 19 in the
district of Trujillo, Peru

Variables in the equation
B

Standard
Error

Wald

df

Sig.

Exp (B)

95% CI for Exp (B)
Lower

Superior

Age

0.108

0.041

7.096

1

0.008

1.114

1.029

1.206

gender

-4.856

1.79

7.392

1

0.007

0.008

0.000

0.258

Cough

-2.901

1.26

5.318

1

0.021

0.055

0.005

0.648

Respiratory Distress

4.497

1.64

7.480

1

0.006

89.703

3.575

2250.718

pain joints

3.614

2.09

3.003

1

0.083

37.099

0.619

222.044

Diabetes

4.350

2.14

4.138

1

0.042

77.478

1.167

5142.378

Constant

-2.657

2.99

0.888

1

0.346

0.060

Summary of the Model:
Logarithm of likelihood -2: 36.398c
Cox and Snell: 0.502
R-squaredNagelkerke's R-squared: 0.699
Hosmer and Lemeshow test:
Chi-square: 8.349
Significance: 0.396
Source: Data obtained from the registry system of COVID19 from the Ministry of Health, March to May 2020.
Note: SPSS version 26, Method ahead of Wald (step 6)
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Table 5. Classification table of observed and predicted cases for the mortality model in hospitalized patients
for COVID 19 of the district of Trujillo, Peru.

Classification table
Predicted
Deceased

Observed

Step 6

Deceased

Percentage
correct

No

Yes

No

40

3

93.0

Yes

3

18

85.7

Global percentage

90.6

ORIGINAL PAPER

Source: Data obtained from the Ministry of Health's COVID19 registry system.
Note: SPSS version 26

Graphic 1. COR curve of the Regression Model Estimated for Mortality in Hospitalized Patients for COVID
19 in the Trujillo District, Peru.
DISCUSSION
The analysis performed on the results shows us that
in Table 1, the mean age of hospitalized patients
was 52.56 years, with deceased patients having
an average age of 64.67 years. Likewise, 68.8% of
hospitalized patients were male. In the same way,
85.7% of this gender predominated in the deceased.
This is confirmed by the majority of investigations
from different parts of the world, as well as the
reports are shown by the MINSA, since the largest
number of deceased people in Peru are those of the
male gender(4).
Published by INICIB-URP, 2021

On the other hand, 92.2% of patients had different
occupations; however, we can see that, in deceased
patients, retirees lead this group with 28.6%.
According to the data analyzed, we can also affirm
that the deceased had approximately 9.7 (+/- 9.9)
days of average length of stay in hospitalization
until their death. This information coincides with the
study carried out at the Hospital de Lima-Perú where
the authors mention that they had a time of illness
until death of 8 days (+/- 3.0)(18) and having a minimal
difference with the study of China since it mentions
that the mean time from admission to death was 5
(3.0-9.3) days(19).
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Table 2 shows that the mean temperature of
hospitalized patients was 37.4 ° C ± 0.97. In deceased
patients, the mean temperature recorded was 37.6°
C ± 0.9. The most frequent signs in hospitalized
patients were dyspnea in 42.2%, abnormal lung
auscultation in 53.1%, and abnormal lung X-ray
findings in 40.6%. In deceased patients, dyspnea,
abnormal lung auscultation, and abnormal X-ray
findings were presented. Pulmonary in 47.6%, 47.6%
and 33.3% respectively. Likewise, in the study carried
out in China, they affirm that fever and cough were
the most frequent symptoms at the beginning of the
disease and that dyspnea and chest tightness were
much more common in deceased patients(19).
Table 2 also shows that the symptoms that most
affected patients hospitalized for COVID-19 were
fever with 79.7%, general malaise with 62.5%, cough,
and respiratory distress in the same frequency with
60.9%. Similar results were obtained in deceased
patients, as the symptoms of fever, general malaise,
cough and respiratory distress in 81.0%, 57.1%,
52.4% and 90.5% were presented within this
group of patients. This is similar to studies such as
those published in Cuba and in our country where
patients suffering from this disease presented similar
symptoms(9).
The most frequent comorbidities of patients
hospitalized for COVID-19 were hypertension in
28.1% of patients and diabetes in 6.3%. In deceased
patients, cardiovascular disease predominated
(including hypertension) in 42.9%, diabetes and
cancer in 14.3% in both comorbidities, as shown
in Table 3. Similar results were found in deceased
patients from China, since The authors mention
that chronic hypertension and other cardiovascular
comorbidities were more frequent among deceased
patients (54 (48%) and 16 (14%)) than recovered
patients (39 (24%) and 7 (4%))(19 ).
Table 4 shows us that a logistic regression model
has been established by selecting the variables age,
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gender, cough, respiratory distress, and diabetes.
Likewise, the fact that a person is older and has
respiratory difficulty are risk factors for mortality
in hospitalized patients. This coincides with the
studies carried out in China and by the Institute of
Experimental Medicine of Peru since they mention
that mortality generally occurs in older adults(6,7).
Among the comorbidities, we find Diabetes as a
risk factor for the mortality of patients hospitalized
for COVID-19. This is corroborated with the research
carried out in Cuba, since the authors mention that
one of the risk comorbidities is diabetes(8).
The results also indicate that the fact of being
female and having a cough reduces the probability
of mortality in patients hospitalized for COVID-19,
corroborating the descriptive results, this is what
was mentioned above, and most studies, as well as
the Ministry of Health confirms it.
The analyzed indicators of the proposed logistic
regression model shown in tables 4, 5, and figure 1
indicate that the model is significant and of good fit,
concluding that it provides excellent discrimination
power. Therefore, our contribution to the research
is the proposal of the logistic regression model to
predict mortality in hospitalized patients with its
associated factors.

CONCLUSION
In conclusion, the results show that the model is
adequate to establish the risk factors for mortality,
being the most significant within the biological
factors age and gender, within the social factors
none were included in the model and within
the clinical ones the cough, respiratory difficulty
and comorbidity, Diabetes. The coefficients of
determination of R squared of Cox and Snell, and R
are acceptable since they show a quite considerable
percentage of explained variation, as well as that the
model would correctly classify 90.6% of the cases.
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